Efficacy and safety of glucagon-like peptide-1 receptor agonists in type 2 diabetes: A systematic review and mixed-treatment comparison analysis. [electronic resource]
Producer: 20171102Description: 524-536 p. digitalISSN:- 1463-1326
- Blood Glucose -- drug effects
- Diabetes Mellitus, Type 2 -- blood
- Drug Administration Schedule
- Exenatide
- Female
- Glucagon-Like Peptide 1 -- administration & dosage
- Glucagon-Like Peptides -- administration & dosage
- Glycated Hemoglobin -- drug effects
- Humans
- Hypoglycemia -- chemically induced
- Hypoglycemic Agents -- administration & dosage
- Immunoglobulin Fc Fragments -- administration & dosage
- Incretins -- administration & dosage
- Liraglutide -- administration & dosage
- Male
- Middle Aged
- Peptides -- administration & dosage
- Randomized Controlled Trials as Topic
- Recombinant Fusion Proteins -- administration & dosage
- Treatment Outcome
- Venoms -- administration & dosage
- Glucagon-Like Peptide-1 Receptor Agonists
No physical items for this record
Publication Type: Journal Article; Meta-Analysis; Review; Systematic Review
There are no comments on this title.
Log in to your account to post a comment.